Journal profile · Medicine-Family Practice
The Lancet Healthy Longevity
ISSN 2666-7568 · Elsevier · United Kingdom
The Lancet Healthy Longevity: CAS Zone 1 · Medicine (2025 upgraded edition, Top journal); impact factor 20.5 (journal website); fully open access; APC about USD 7,860; median 111 days to acceptance (79 articles, last 24 months); 132 articles in 2025; indexed in Scopus.
Scope
Aims, scope and focus
The Lancet Healthy Longevity is published by Elsevier and is in Zone 1 of Medicine in the CAS Journal Ranking (2025 upgraded edition, Top journal). By OpenAlex counts of its recent articles, its largest topics are Frailty in Older Adults, Dementia and Cognitive Impairment Research and Health Systems, Economic Evaluations, Quality of Life, together about 33.2% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
The Lancet Healthy Longevity is a gold open-access, multi-disciplinary journal that publishes clinically-focussed longevity and healthy ageing research and review. The broad research remit aims to encompass early-stage clinical research into the mechanisms of ageing at any stage of life through to epidemiological and societal research on changing populations, including clinical trials in all disciplines focussed, but not exclusively, on older people, gerontological science, and age-specific clinical guidelines. We will also publish clinical and policy reviews which aim to shape and contextualise the debate on this fast-growing discipline.The Lancet Healthy Longevity will continue in the Lancet family tradition of being a strong advocate for the rights of all people to healthy, fulfilling lives, irrespective of age, and prioritises reports of original research that are likely to change clinical practice or thinking.
From the journal's Aims & Scope
Research area (LetPub): Medicine-Family Practice
Main research topics OpenAlex counts of recent articles; shares are approximate
- Frailty in Older AdultsMedicine14.9%
- Dementia and Cognitive Impairment ResearchMedicine11.3%
- Health Systems, Economic Evaluations, Quality of LifeEconomics, Econometrics and Finance7%
- Chronic Disease Management StrategiesMedicine6.6%
- Nutrition and Health in AgingMedicine6.3%
- Health disparities and outcomesSocial Sciences6%
- Geriatric Care and Nursing HomesHealth Professions5.1%
- Intensive Care Unit Cognitive DisordersMedicine3.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Geriatrics & Gerontology | Zone 1 |
Top journal: yesReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Geriatrics & Gerontology | Zone 1 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ScopusDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher)
- 20.5Publisher website ·
- CiteScore 2026-06
- 24.2LetPub ·
- CiteScore (publisher)
- 24.2Publisher website ·
- SJR 2026-06
- 5.43LetPub ·
- SNIP 2026-06
- 4.64LetPub ·
- h-index
- 80OpenAlex ·
- i10-index
- 383OpenAlex ·
- 2-year mean citedness
- 12.16OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Articles by year OpenAlex count · 891 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 94 | 94 | 75 |
| 2025 | 132 | 132 | 1,057 |
| 2024 | 141 | 141 | 3,330 |
| 2023 | 149 | 149 | 3,607 |
| 2022 | 171 | 171 | 5,732 |
| 2021 | 173 | 173 | 7,534 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
111 daysMedian, submission to acceptance · P25–P75 40 days – 171 days
- Acceptance to online
- median 49 days (76 articles)
- Submission to online
- median 166 days
- Sample
- 79 articles with submission and acceptance dates (250 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 12 weeksLetPub ·
- Submission to first decision
- 4 daysPublisher website ·
- First decision after review
- 64 daysPublisher website ·
- Submission to acceptance
- 101 daysPublisher website ·
- Acceptance to publication
- 54 daysPublisher website ·
- Submission to publication (journal-reported)
- about 30 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | USD 7,860 | Yes | CC BY, CC BY-NC, CC BY-NC-ND | |
| OpenAlex | USD 6,680 / EUR 6,250 / GBP 5,350 / JPY 828,520 | — | — | |
| LetPub | USD 5,500 | Yes | — | |
| Publisher website | USD 7,860 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websiteOpen access
- Open access Open Access
Article Publishing Charge (APC): USD 7,860 (excluding taxes). This journal is taking part in the GPOA program.Review this journal’s open access policy.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Elsevier
- Country or region
- United Kingdom
- Language
- English
- ISSN
- 2666-7568
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about The Lancet Healthy Longevity
What CAS zone is The Lancet Healthy Longevity in?
In the 2025 upgraded edition of the CAS Journal Ranking, The Lancet Healthy Longevity is in Zone 1 of Medicine, and in Zone 1 of the minor category Geriatrics & Gerontology; it is a Top journal. In the 2026 Xinrui edition it is in Zone 1 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of The Lancet Healthy Longevity?
The journal's website gives an impact factor of 20.5; this is the journal's own figure, as LetPub lists none for it; CiteScore 24.2, h-index 80.
How long does peer review take at The Lancet Healthy Longevity?
Based on the dates recorded on 79 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 111 days (interquartile range 40–171 days); authors report an average review time of about 12 weeks. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index The Lancet Healthy Longevity?
According to LetPub and DOAJ records, The Lancet Healthy Longevity is indexed in Scopus and DOAJ.
Is The Lancet Healthy Longevity open access, and what is the APC?
The Lancet Healthy Longevity is a fully open-access journal. APC about USD 7,860.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .